ProfileGDS5822 / ILMN_2453351
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 19% 1% 24% 9% 2% 10% 8% 22% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.719
GSM1276600PDAC Late Ablation Control 26.41
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 112.224
GSM1276603PDAC Late Ablation 28.29
GSM1276604PDAC Late Ablation 32.92
GSM1303940PDAC Late Ablation_anti-CTLA4 19.510
GSM1303941PDAC Late Ablation_anti-CTLA4 25.88
GSM1303942PDAC Late Ablation_anti-CTLA4 311.222